David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Campbell Soup
CPB
$6.94B
| $2.29M | ﹤0.01% |
102,904
-44,675
| -30% | -$1.15M |
|
2727
PUT
Emcor
EME
$34.2B
| $2.29M | ﹤0.01% |
3,100
+200
| +7% | +$146K |
|
2728
Pinnacle West Capital
PNW
$11.9B
| $2.28M | ﹤0.01% |
22,631
-28,467
| -56% | -$2.75M |
|
2729
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $2.28M | ﹤0.01% |
49,592
-219,179
| -82% | -$9.83M |
|
2730
Henry Schein
HSIC
$10.1B
| $2.27M | ﹤0.01% |
30,829
-63,803
| -67% | -$4.93M |
|
2731
Bio-Rad Laboratories Class A
BIO
$10.4B
| $2.27M | ﹤0.01% |
8,145
+3,315
| +69% | +$955K |
|
2732
PUT
Rivian
RIVN
$24.3B
| $2.26M | ﹤0.01% |
150,000
-2,419,500
| -94% | -$38.7M |
|
2733
Radiant Logistics
RLGT
$408M
| $2.25M | ﹤0.01% |
318,573
+130,608
| +69% | +$916K |
|
2734
The Bancorp
TBBK
$2.71B
| $2.25M | ﹤0.01% |
41,788
+27,832
| +199% | +$1.67M |
|
2735
Puma Biotechnology
PBYI
$477M
| $2.24M | ﹤0.01% |
351,235
-27,061
| -7% | -$175K |
|
2736
Cerence
CRNC
$380M
| $2.24M | ﹤0.01% |
355,178
+223,203
| +169% | +$2.01M |
|
2737
Altimmune
ALT
$630M
| $2.24M | ﹤0.01% |
727,001
-616,582
| -46% | -$2.62M |
|
|
YSS
2738
York Space Systems
YSS
$1.26B
| $2.24M | ﹤0.01% |
+100,926
| New | +$2.45M |
|
2739
Seadrill
SDRL
$3.03B
| $2.24M | ﹤0.01% |
49,139
-11,598
| -19% | -$473K |
|
2740
Array Technologies
ARRY
$719M
| $2.23M | ﹤0.01% |
309,128
-2,250,248
| -88% | -$20.8M |
|
2741
Graco
GGG
$12.9B
| $2.23M | ﹤0.01% |
26,301
+13,628
| +108% | +$1.21M |
|
2742
CALL
Dollar General
DG
$27.8B
| $2.22M | ﹤0.01% |
18,700
-100,700
| -84% | -$14.4M |
|
|
GDEN
2743
DELISTED
Golden Entertainment
GDEN
| $2.22M | ﹤0.01% |
83,157
-131,796
| -61% | -$3.65M |
|
2744
Twist Bioscience
TWST
$9.6B
| $2.22M | ﹤0.01% |
46,644
+19,063
| +69% | +$855K |
|
2745
Acadia Healthcare
ACHC
$2.81B
| $2.22M | ﹤0.01% |
94,721
-973,443
| -91% | -$17.6M |
|
2746
CALL
Deutsche Bank
DB
$75.3B
| $2.19M | ﹤0.01% |
73,500
| – | – |
|
2747
CRA International
CRAI
$1.08B
| $2.18M | ﹤0.01% |
13,463
+6,879
| +104% | +$1.24M |
|
2748
Aptiv
APTV
$9.43B
| $2.18M | ﹤0.01% |
31,370
-11,255
| -26% | -$867K |
|
2749
Peapack-Gladstone Financial
PGC
$801M
| $2.17M | ﹤0.01% |
61,761
-21,443
| -26% | -$697K |
|
2750
Duke Energy
DUK
$94.2B
| $2.17M | ﹤0.01% |
16,598
+4,633
| +39% | +$579K |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.